Please login to the form below

Kevzara

This page shows the latest Kevzara news and features for those working in and with pharma, biotech and healthcare.

Roche’s anti-inflammatory drug reduces deaths in hospitalised COVID-19 patients

Results from the REMAP-CAP trial found that tocilizumab, as well as Sanofi’s Kevzara (sarilumab), reduced mortality by 8.6%, and also improved recovery times among patients who are critically

Latest news

UK study finds antibiotics azithromycin and doxycycline ineffective against COVID-19

Earlier this month, a study led by Imperial College London, known as REMAP-CAP, found that Roche’s Actemra (tocilizumab) and Sanofi’s Kevzara (sarilumab) cut the risk of death in ... This trial found that both Actemra and Kevzara reduced mortality by
Two drugs found to reduce mortality in severe COVID-19 patients

Actemra and Kevzara also improved recovery times among critically ill COVID-19 patients. ... Both Actemra and Kevzara are IL-6 receptor agonists and are most commonly used to treat anti-inflammatory conditions, including arthritis.
Novartis’ canakinumab failed to improve survival in COVID-19 study

This includes Roche’s Actemra (tocilizumab) and Sanofi and Regeneron’s Kevzara (sarilumab), with both drugs entering clinical trials evaluating their efficacy in severely ill COVID-19 patients. ... Kevzara was also unable to prevent death or help
Lilly’s Olumiant combined with Gilead’s remdesivir hits the mark in COVID-19

This includes Sanofi’s Kevzara (sarilumab) and Roche’s Actemra (tocilizumab), although both of these drugs failed their respective studies in COVID-19. ... Despite the disappointing results, Roche is continuing its investigation of Actemra in severe
AbbVie, Amgen and Takeda team up for joint COVID-19 trial

A number of other anti-inflammatory drugs have also failed to hit the mark in COVID-19, including Sanofi/Regeneron’s rheumatoid arthritis drug Kevzara (sarilumab) and Roche’s Actemra (tocilizumab).

More from news
Approximately 6 fully matching, plus 26 partially matching documents found.

Latest Intelligence

As COVID-19 takes over the world, biopharma fights back

Evaluating IL-6 inhibitors: Roche’s Actemra and Sanofi and Regeneron’s Kevzara. Roche, Sanofi and Regeneron are also looking to repurpose their existing treatments and are currently testing their ... Encouraged by this initial data, Sanofi and

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Client Services Director, Patient Engagement & Solutions, Lo...: Highly competitive salary

Senior Account Manager: Salary TBC

Editor & Senior Editor - Medical Communications - Home Based: Highly Competitive Salary, Bonus &Benefits

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

FREELANCE (Outside IR35) Opportunities for this week below!!!: Superb Day Rate

Medical Writer, Senior Medical Writer, Principal Medical Writer,...: Highly Competitive Salary, Bonus &Benefits

Senior Account Director, Publications, Women’s health, Medical C...: Highly competitive salary

Associate Medical Writer / Entry Level Medical Writer - Medical ...: DOE

Senior Account Director, Publications, Opthalmology, Medical Com...: Highly competitive salary

Publications Director: Competitive Salary

Medical Writer, Women’s health, Medical Communications agency, h...: Highly competitive salary

Group Account Director, Patient Engagement & Solutions, Lond...: Highly competitive salary

Planner: Salary TBC

Senior Account Director & Associate Director - Healthcare Ad...: Highly Competitive Salary, Bonus &Benefits

Client Services Director – London or Home Based – Medical Commun...: Highly Competitive Salary, Bonus &Benefits

Senior Medical Writer, Rare diseases, Medical Communications age...: Highly competitive salary

Home Working Medical Copy Writer & Senior Medical Copy Write...: Highly Competitive Salary, Bonus &Benefits

Account Director, Publications, Opthalmology, Medical Communicat...: Highly competitive salary

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

PMHub

Add my company

Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

How early-stage clinical research is facilitating the new wave of personalised medicines: By Jorg Taubel...
Patient diversity in clinical trials needs to be centre stage: By Danny Buckland...
Why empathy in digital patient recruitment is vital: This is where empathy mapping can be incredibly effective....

Email:
Password:

Please login to the form below

Kevzara

COVID-19 Updates and Daily News

Featured jobs

Quick links